RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
University of Pittsburgh
University of Pittsburgh
H. Lee Moffitt Cancer Center and Research Institute
University of Pittsburgh
H. Lee Moffitt Cancer Center and Research Institute
CivaTech Oncology
Rhode Island Hospital
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
Radiopharm Theranostics, Ltd
Ohio State University Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Indiana University
Shanghai Juncell Therapeutics
University of Virginia
Assistance Publique - Hôpitaux de Paris
Dana-Farber Cancer Institute
Abramson Cancer Center at Penn Medicine
H. Lee Moffitt Cancer Center and Research Institute
Mayo Clinic
Fox Chase Cancer Center
The University of Hong Kong-Shenzhen Hospital
Centre Jean Perrin
University of Massachusetts, Worcester
University of Southern California
Miltenyi Biomedicine GmbH
Presage Biosciences
Northwestern University
Xijing Hospital
University of Lausanne Hospitals
University of Virginia
Center for Biomedical Research, Inc.
Shanghai Yunying Medical Technology
University of Pennsylvania
Columbia University
Ohio State University Comprehensive Cancer Center
Rutgers, The State University of New Jersey
TuHURA Biosciences, Inc.
Yale University
Presage Biosciences
Shanghai Fengxian District Central Hospital
University of Missouri-Columbia
Northwestern University
Yale University
Center for Biomedical Research, Inc.
Northwestern University
Rhode Island Hospital
Johns Hopkins University
Tulane University
Stanford University